Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | AMGN | GILD | CELG | ILMN |
| Company | Ascendis Pharma ADR | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 140.59 | 273.45 | 67.47 | 108.01 | 121.97 |
| High | 140.84 | 274.35 | 67.90 | 108.59 | 122.04 |
| Low | 136.19 | 267.24 | 65.09 | 107.27 | 116.91 |
| Last | 136.93 | 269.38 | 65.27 | 108.24 | 121.05 |
| Change | -6.25 | -3.63 | -1.81 | +0.11 | -1.82 |
| % Change | -4.37% | -1.33% | -2.70% | +0.10% | -1.48% |
| Volume | 366,615 | 1,759,092 | 13,947,839 | 191,230,496 | 961,337 |
| 20-Day Average Volume | 297,987 | 2,115,604 | 6,652,872 | 16,188,930 | 1,502,990 |
| Previous Close | 143.18 | 273.01 | 67.08 | 108.13 | 122.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 146.33 | 270.70 | 68.68 | 108.17 | 125.62 |
| 20-Day Raw Stochastic | 7.70% | 30.98% | 0.80% | 63.25% | 20.91% |
| 20-Day Relative Strength | 41.82% | 44.75% | 28.07% | 64.69% | 41.86% |
| Weighted Alpha | +69.51 | +9.08 | -23.91 | +46.30 | -38.71 |
| Today's Opinion | 24% Buy | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 40% Buy | 40% Sell | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 100% Buy | 24% Buy | 88% Sell | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.21% since 04/18/24 | +2.50% since 04/18/24 | -1.51% since 04/18/24 | -1.97% since 11/13/19 | +3.54% since 04/18/24 |
| Low | 136.19 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 107.27 on 11/20/19 | 116.61 on 04/19/24 |
| High | 147.45 on 04/23/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 110.53 on 11/14/19 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | -4.62% since 03/25/24 | -4.10% since 03/25/24 | -10.22% since 03/25/24 | +5.14% since 10/18/19 | -9.88% since 03/25/24 |
| Low | 136.19 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 156.84 on 04/10/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | +4.58% since 01/25/24 | -13.20% since 01/25/24 | -18.78% since 01/25/24 | +13.63% since 08/20/19 | -15.37% since 01/25/24 |
| Low | 127.95 on 01/31/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 161.00 on 02/26/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +59.65% since 10/25/23 | -1.04% since 10/25/23 | -16.88% since 10/25/23 | +14.14% since 05/20/19 | +6.05% since 10/25/23 |
| Low | 85.70 on 10/26/23 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 161.00 on 02/26/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,336,511 | 146,436,016 | 83,519,768 | 77,035,920 | 19,567,662 |
| Shares Outstanding, K | 58,224 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 288,670,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -521,070,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 148,660,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -93,040,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 0.50 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.66 on 02/07/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 04/25/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 10.99 | 143.06 |